Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Metoprolol recalled?

Yes — there is an active recall. 9 ongoing FDA recalls mention Metoprolol (43 total). Check the affected lots below.

Most common reason: Dissolution failure (19 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Metoprolol. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Metoprolol recalls in 2026

5 initiated in 2026, 43 in total — newest first
Class II · Moderate risk

Metoprolol Tartrate Tablets

CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.

Ongoing Nitrosamine impurity Westminster Pharmaceuticals LLC NDC 69367-355-10 D-0582-2025
Class II · Moderate risk

Metoprolol Tartrate Tablets

CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.

Ongoing Nitrosamine impurity Westminster Pharmaceuticals LLC NDC 69367-354-10 D-0581-2025
Class II · Moderate risk

Metoprolol Succinate Extended-Release Tablets

Failed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH) long-term.

Ongoing Dissolution failure Granules Pharmaceuticals Inc. NDC 70010-780-01 D-0510-2025
Class II · Moderate risk

Metoprolol Succinate Extended-Release Tablets

Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer which included lots that were packaged for BluePoint Laboratories.

Terminated Dissolution failure Amerisource Health Services LLC NDC 68001-501-00 D-0269-2023
Class III · Low risk

Metoprolol Tartrate Injection

Failed pH Specifications: High Out-of-Specification results for pH were obtained during stability testing.

Terminated Failed specification RemedyRepack Inc. NDC 70518-0868-00 D-0245-2019
Class III · Low risk

Metoprolol Tartrate Injection

Failed pH Specifications: Upward shift in the pH of the solution within the shelf life of the impacted lots.

Terminated Failed specification Baxter Healthcare Corporation D-0222-2019